Framingham biotech strikes DOD partnership as it marches toward IPO

Two months post-acquisition, BPGbio has signed a new, five-year partnership with the Department of Defense and laid out a near-term plan to get to the public markets.

Previous State Street CEO's compensation has nearly doubled in two years
Next Luxury listings: Lakefront home tops Statesville market with $3.15M price tag